Arash A. Alizadeh, Ph.D.
Affiliations: | 2003 | Stanford University, Palo Alto, CA |
Area:
gene expressionGoogle:
"Arash Alizadeh"Parents
Sign in to add mentor| Patrick O. Brown | grad student | 2003 | Stanford | |
| (Genome-scale characterization of normal and pathological gene expression programs in immune cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chabon JJ, Hamilton EG, Kurtz DM, et al. (2020) Integrating genomic features for non-invasive early lung cancer detection. Nature. 580: 245-251 |
| Phillips R, Shi WY, Deek M, et al. (2020) Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. Jama Oncology |
| Hellmann MD, Nabet BY, Rizvi H, et al. (2020) Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| King D, Alizadeh AA, Fisher GA. (2020) Detection of circulating tumor DNA in pancreas cancer. Journal of Clinical Oncology. 38: 645-645 |
| Newman AM, Nakao A, Li K, et al. (2020) Analytical validation of iSort digital cytometry for leukocyte enumeration in clinical tumor specimens. Journal of Clinical Oncology. 38: e15243-e15243 |
| Murciano-Goroff YR, Hui AB, Chabon JJ, et al. (2020) Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer. Journal of Clinical Oncology. 38: 9067-9067 |
| Moding EJ, Esfahani MS, Nabet B, et al. (2020) A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction. Journal of Clinical Oncology. 38: 9046-9046 |
| Binkley MS, Jeon Y, Nesselbush M, et al. (2020) KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer. Journal of Clinical Oncology. 38: 9012-9012 |
| Newman AM, Nakao A, Li K, et al. (2020) Analytical validation of digital cytometry (iSort) for leukocyte enumeration using stored blood. Journal of Clinical Oncology. 38: 3542-3542 |
| Esfahani MS, Lee LJ, Jeon YJ, et al. (2019) Functional significance of U2AF1 S34F mutations in lung adenocarcinomas. Nature Communications. 10: 5712 |